ExploreWatchlistsPricing
  1. JP-listed companies
  2. SAWAI GROUP HOLDINGS Co., Ltd.
  3. Financials
  4. EBITDA

SAWAI GROUP HOLDINGS Co., Ltd. (4887)

Market cap
¥290.3B
P/E ratio
18.2x
Sawai Group Holdings manufactures and sells prescription and over-the-counter pharmaceuticals through its domestic subsidiaries in Japan.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 202519,291-47.40%
Mar 31, 202436,675+5.79%
Mar 31, 202334,667-283.98%
Mar 31, 2022-18,843

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat